“…3,5 Previous studies have reported an association between IFIS and intake of α-blockers, which are commonly used for the treatment of benign prostatic hyperplasia. Specifically, IFIS was independently associated with tamsulosin, 1,6-10 doxazosin, 2,9,11 terazosin, 12 alfuzosin, 8,10,13 silodosin, 14 or labetalol, a selective α-and β-blocker. 15 Interestingly, a meta-analysis of the risk factors for IFIS demonstrated a hierarchy in the magnitude of the associations between the various α-blockers and IFIS.…”